investorscraft@gmail.com

Intrinsic Value of Horizon Therapeutics Public Limited Company (HZNP)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %12.5NaN
Revenue, $3629NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m3012NaN
Operating income, $m617NaN
EBITDA, $m1072NaN
Interest expense (income), $mNaN
Earnings before tax, $m527NaN
Tax expense, $m5NaN
Net income, $m521NaN

BALANCE SHEET

Cash and short-term investments, $m2358NaN
Total assets, $m9115NaN
Adjusted assets (=assets-cash), $m6757NaN
Average production assets, $m4167NaN
Working capital, $m2704NaN
Total debt, $m2563NaN
Total liabilities, $m4042NaN
Total equity, $m5072NaN
Debt-to-equity ratio0.505NaN
Adjusted equity ratio0.404NaN

CASH FLOW

Net income, $m521NaN
Depreciation, amort., depletion, $m454NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m1258NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-64NaN
Free cash flow, $m1322NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m2704
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount